US approves Pfizer vaccine for ages 12-15

Updated May 11 2021 - 7:39am, first published 7:34am
The pace of US vaccinations has slowed significantly since peaking in mid-April.
The pace of US vaccinations has slowed significantly since peaking in mid-April.

US regulators have authorised Pfizer and BioNTech's COVID-19 vaccine for use in children as young as 12, widening the country's inoculation program as vaccination rates have slowed significantly.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Canberra news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.